US News

Trump Boasted About A ‘New’ Apple Plant In Texas. It Opened In 2013.

President Donald Trump traveled to Austin, Texas, on Wednesday to tour a manufacturing plant with Apple chief executive Tim Cook, touting what he called a “new” facility that would bring high-paying jobs back to America.
The only problem? The plant has been making Apple computers since 2013, long before Trump was elected.
The president toured a facility run by an independent company called Flex Ltd. that assembles Apple’s expensive Mac Pro computers. During the tour, Trump suggested that his efforts to convince companies to relocate their manufacturing facilities back to the U.S. — and in particular, his relationship with Cook over the past few years — had paid off.
“We’re seeing the beginning of a very powerful and important plant,” said Trump, who has long boasted about his efforts to convince manufacturers to come back to America. “Anybody that followed my campaign, I would always talk about Apple, that I want to see Apple building plants in the United States. And that’s what’s happening.”
But that assertion is not true, and Cook did not correct Trump after he made the statements.
President Trump just toured a Texas plant that has been making Apple computers since 2013 and took credit for it, suggesting the plant opened today. “Today is a very special day.” Tim Cook spoke immediately after him and did not correct the record.— Jack Nicas (@jacknicas) November 20, 2019

I don’t know why @tim_cook didn’t correct the president.I do know that Apple assembles most of its products in China, making many potentially subject to tariffs.I also know @tim_cook wants tariff waivers. When asked today about it, Mr. Trump said: “We’ll look into that.”— Jack Nicas (@jacknicas) November 21, 2019

The New York Times’ Jack Nicas noted shortly after the event that Apple has not, in fact, built any new plants in the U.S. since Trump’s election and that the vast majority of its products are still made overseas.
The tech giant did release more details about its previously announced $1 billion campus in Austin that will house 5,000 white-collar employees beginning in 2022. But those roles will, by and large, not be manufacturing jobs.
“With the construction of our new campus in Austin now underway, Apple is deepening our close bond with the city and the talented and diverse workforce that calls it home,” Cook said in a company statement.
Trump repeated his falsehood on Twitter later in the day, saying, “Today I opened a major Apple Manufacturing plant in Texas that will bring high paying jobs back to America.” He also shared a video of his tour of the plant.
Today I opened a major Apple Manufacturing plant in Texas that will bring high paying jobs back to America. Today Nancy Pelosi closed Congress because she doesn’t care about American Workers!— Donald J. Trump (@realDonaldTrump) November 20, 2019

Trump commended Apple for building the Mac Pro in the U.S. on Wednesday, saying that by doing so, Cook didn’t “have to worry about tariffs” that would affect the cost of the final product.
That’s also false. The Verge notes that some Mac Pro parts are imported from China, and Apple has to pay tariffs on them before the devices are assembled in Texas. A new round of tariffs is set to go into effect on Dec. 15, and it will potentially affect the cost of a bevy of Apple products, including iPhones.
Apple was flirting with the idea of moving production overseas earlier this year to lower the costs of the Mac Pro but said in September that the latest iteration of the computer would be assembled in Austin after all.
The president also tweeted another confusing lie on Wednesday, saying House Speaker Nancy Pelosi (D-Calif.) had “closed Congress” on Wednesday, apparently pointing to the ongoing impeachment investigation into the Trump administration’s dealings with Ukraine.
Congress was not closed. Many House lawmakers were holding those hearings. Meanwhile, the Senate advanced an important bill addressing the crisis of missing and murdered Native American women.

Help us tell more of the stories that matter from voices that too often remain unheard.

Source link

US News

OxyContin Maker Thrives In China With Abandoned U.S. Tactics

SHANGHAI (AP) — Thousands of lawsuits across the United States have accused a drug company owned by the billionaire Sackler family of using false claims to push highly addictive opioids on an unsuspecting nation, fueling the deadliest drug epidemic in U.S. history.
Yet, even as its U.S. drugmaker collapses under the charges, another company owned by the family has used the same tactics to peddle its signature painkiller, OxyContin, in China, according to interviews with current and former employees and documents obtained by the Associated Press.
The documents and interviews indicate that representatives from the Sacklers’ Chinese affiliate, Mundipharma, tell doctors that time-release painkillers like OxyContin are less addictive than other opioids—the same pitch that Purdue Pharma, the U.S. company owned by the family, admitted was false in court more than a decade ago.

EDITOR’S NOTE: The Associated Press, supported by a grant from the Pulitzer Center on Crisis Reporting, is investigating the global spread of opioids and its consequences.

Mundipharma has pushed ever larger doses of the drug, even as it became clear that higher doses present higher risks, and represented the drug as safe for chronic pain, according the interviews and documents.
These tactics mirror those employed by Purdue Pharma in the U.S., where more than 400,000 people have died of opioid overdoses and millions more became addicted. An avalanche of litigation over the company’s marketing has driven Purdue Pharma into bankruptcy in the U.S.
In China, Mundipharma managers have required sales representatives to copy patients’ private medical records without consent, in apparent violation of Chinese law, current and former employees told AP. Former reps also said they sometimes disguised themselves as medical staff, putting on white doctor’s coats and lying about their identity to visit patients in the hospital. As in the U.S., marketing material in China made claims about OxyContin’s safety and effectiveness based on company-funded studies and outdated data that has been debunked.
The AP examined more than 3,300 pages of training and marketing materials used by Mundipharma staff, as well as internal company documents and videos. These files came from three independent sources and were verified by cross-checking. AP also spoke with one current and three former OxyContin sales representatives who worked at the company last year.
Mundipharma has promoted its blockbuster product, OxyContin, in questionable ways in other countries, including Italy and Australia. But the company has particularly high hopes for China — the world’s most populous nation and second largest economy— where it has said it wants sales to surpass those in the U.S. by 2025.
Though Mundipharma and Purdue are separate legal entities, both are owned by the Sackler family. Today, Mundipharma is a bargaining chip in negotiations to settle sweeping U.S. litigation. The Sackler family agreed to cede ownership of Purdue, but wants to keep Mundipharma for now to sell OxyContin abroad. They have discussed eventually selling Mundipharma to fund the family’s contribution to a nationwide settlement in the U.S.
Mundipharma said it was taking immediate action to investigate the allegations uncovered by AP. In a statement, the company did not respond to specific allegations but said it has rigorous policies in place “to ensure that our medicines are marketed responsibly and in accordance with China’s strict regulatory framework governing analgesics.”
In response to detailed questions, Purdue said Mundipharma is an independent entity, operating in a different country, under different laws and regulations. Representatives of the Sackler family did not respond to detailed requests for comment.
In the United States, Purdue stopped promoting OxyContin to doctors in 2018 and got rid of its entire opioid sales staff.
Meanwhile, Mundipharma is hiring in China.

Mundipharma China was born in 1993 in a signing ceremony at the Great Hall of the People on Tiananmen Square. Just as in the U.S., the Sackler family’s business interests in China coincided with their philanthropy.
The month after Mundipharma’s creation, the Arthur M. Sackler Museum of Art and Archeology opened its doors at Peking University in Beijing. Outside the museum is a statue dedicated to Arthur Sackler and his wife by the China Medical Tribune, a journal he helped found that now claims a readership of more than a million Chinese doctors.
These seeds of philanthropy and political alliances would bear fruit for the Sacklers just as opioid prescriptions began to fall in the U.S.
China was a tantalizing market for the Sacklers. The country’s per capita consumption of opioids was low and it had millions of new cancer cases every year.
But if convincing U.S. doctors in America that opioids are safe was a hard sell, in China, it would be even more difficult.
China fought two wars in the 19th century to beat back British ships dumping opium that fueled widespread addiction. Today, the cultural aversion to taking drugs — in Chinese, literally “sucking poison” — is so strong addicts can be forced into police-run treatment centers. The country does not appear to have an opioid crisis anything like in the U.S.
Two decades ago, as stories of OxyContin abuse began to circulate in the United States, foreign pharmaceutical companies helped spread a new gospel of pain treatment across China, recasting pain as the fifth vital sign—alongside blood pressure, heart rate, respiratory rate, and temperature—and pain treatment as a human right.
Dr. Yu Buwei, director of anesthesiology at Shanghai’s prestigious Ruijin Hospital, was skeptical. Philosophical and soft-spoken, Yu was deeply grounded in traditional Chinese medicine. During China’s Cultural Revolution he used acupuncture as anesthesia on patients undergoing major surgery.
“It is necessary to treat pain,” Yu said. “We agree with this. But raising it to a human right and the fifth vital sign, we think is controversial.”
Many of his younger colleagues, however, appeared in thrall of these foreign ideas. They believed the best medical practices came from the United States. Few understood how deeply the Western consensus about pain had been shaped by the financial self-interest of pharmaceutical companies.
“In China, doctor’s groups, especially the young doctors, show their respect to American doctors or the European doctors,” Yu said. “What they say, that’s truth. What you say, that’s interfering.”
In 2007, Purdue and three executives pleaded guilty in U.S. court to misrepresenting OxyContin as less addictive than other opioid painkillers, and paid $635 million in penalties, one of the largest settlements in pharmaceutical company history.
Sackler family members began to worry about a “dangerous concentration of risk” in their U.S. business, and trained their sights on the global market. Not long after, Mundipharma helped launch a campaign to improve cancer pain care in China called Good Pain Management, or GPM, according to interviews and company documents.
Today, the program is portrayed as a government public health initiative. But Zhang Li, director of internal medicine at Sun Yat-sen University Cancer Center in Guangzhou, said GPM “got the energetic support of Mundipharma during the launch process.”
According to Zhang, the GPM campaign was started in 2009 under his leadership, by a group within the Guangdong Provincial Anti-Cancer Association, a non-profit that accepts corporate funding. Pharmaceutical companies helped by covering the cost of training and educational materials, he said.
Two years later, the Chinese government launched the campaign nationwide. On February 22, 2011, Mundipharma won a contract to implement the program with an initial target of establishing model GPM wards in 150 key hospitals within three years.
It was a watershed moment for the company.
Mundipharma was responsible for helping train doctors and educate patients, as well as distributing pamphlets and placards to raise awareness about pain. “Mundipharma will eventually become your best supporter and partner in creating a demonstration ward,” proclaimed a PowerPoint assembled in 2009.
The program was a three-way alliance among the then-Ministry of Health, the Chinese Society of Clinical Oncology and Mundipharma, according to Zhang and presentations used by Mundipharma sales staff.
Mundipharma’s initial contract with the oncology society gave it a seat on the GPM leadership team and barred the company from using the program to market its products, according to sections of the contract obtained by AP. In internal company documents, however, Mundipharma treated the program as part of its marketing strategy and used it to tout the superiority of its own products.
“We were definitely talking about OxyContin ninety percent of the time,” said a former sales rep who spoke on condition of anonymity for fear of retribution.
The oncology society declined to answer questions. China’s Ministry of Health, which was reorganized as the National Health Commission, said it hadn’t designated a company to provide assistance for the program.
One GPM presentation that Mundipharma employees said was still being used last year suggested OxyContin is the preferred option for cancer pain treatment under World Health Organization and other guidelines, before detailing why competing painkillers such as acetaminophen, fentanyl patches and immediate release morphine aren’t recommended.
The WHO does not recommend OxyContin as superior to other drugs for cancer pain care.
In a statement to AP, the company said its role in GPM is only to assist with implementation. “The Program is independently initiated and managed with the goal of improving the medical community’s understanding of cancer pain management treatments,” the company said.
Mundipharma told AP that all marketing materials undergo multi-level approval. But current and former employees acknowledged that they sometimes altered the officially-vetted presentations. The messages contained in all three sets of documents were consistent and contained information that Purdue Pharma has used in the United States.
In the years after GPM rolled out, from 2012 through 2018, sales of Mundipharma’s oxycodone, the active ingredient in OxyContin, at nearly 700 of China’s major hospitals rose five-fold, according to previously unreported data from the government-linked China National Pharmaceutical Industry Information Center.
During that same period, sales of morphine, widely considered an affordable “gold standard” for pain treatment, remained flat at those same hospitals. By early 2017, OxyContin had captured roughly 60 percent of the cancer pain market in China, up from just over 40 percent in 2014, company documents show.
Tony Chen, a former OxyContin sales rep who spoke on condition that he be identified by his English name, for fear of retribution, said he loved GPM because the government backing got him high-level access at hospitals and helped drive sales.
“We didn’t need to bribe,” he said. “That’s why I liked it.”
The pressure to perform was intense. Chen and other reps said quarterly sales targets rose by as much as 30 percent. If he surpassed them, he could more than double his take home pay. If he didn’t, he could lose his job.
He said he was prepared to “get fired up” about driving growth. He wasn’t prepared to break the law.
One current and three former sales reps who worked in different parts of China told the AP that managers required them to upload patients’ medical records, obtained without consent, to a company chat group each day.
AP was shown snapshots of prescription records staff said were sent to managers. Handwritten on pink slips of paper, they included the patient’s full name, age, phone number, ID number, diagnosis and prescription.
The more precise the information, the better Mundipharma could plan sales targets, as well as guide doctors to increase dosages and switch to OxyContin from rival drugs, former sales reps explained.
Chen knew he had no legal right to copy personal information, and at first scribbled over patients’ names before uploading the documents. He and his colleagues said they used to discreetly snap photos of patient records during the night shift, or during lunch breaks.
Ultimately, Chen said, he decided his effort to protect privacy was a waste of time because other people in his group were uploading full patient records. He told himself it was OK because the information wouldn’t circulate outside Mundipharma.
When it was time for hospital rounds, Chen sometimes slipped on a white doctor’s coat and mingled with medical staff. If anyone asked who he was, he lied and told them he was a doctor or an intern. He said he sometimes asked patients directly if they felt sore, swollen or numb and how they were sleeping.
Two other former OxyContin sales reps said they also disguised themselves in doctor’s coats and sat in on patient meetings.
The key to this access was good relationships with doctors. Just as Purdue was accused of doing in the U.S., Mundipharma cultivated doctors with paid speaking gigs, dinners, event sponsorships and expense-paid trips to meetings, sometimes routing payments through third parties, sales reps said. Speakers, who sometimes delivered presentations created by or with Mundipharma sales staff, could earn 500 yuan ($70) to several thousand yuan per speech, current and former employees said.
Two of Chen’s former colleagues said they also used gift cards to encourage doctors to prescribe more. It was easy to fake receipts for company expense reports and get cash to fund under-the-table payments, they claimed.
Mundipharma told AP it promotes ethical behavior and compliance with Chinese law through internal monitoring as well as external audits. “We have detailed policies covering interactions with healthcare professionals, grants and donations, and sponsorships and incentives,” the company said, adding that a compliance team monitors expense claims and meetings.
China has some of the strictest regulation in the world on the use of opioids. Opioid painkillers like OxyContin are not available at pharmacies. They are stored under double-lock at hospitals and governed by so-called “red prescriptions,” which only specially certified doctors can write.
But as pain treatment expanded in China, with the establishment of pain clinics beginning in 2007 and the rollout of GPM, more doctors became certified to prescribe opioids. Pain management ceased to be the purview of anesthesiologists like Ruijin Hospital’s Dr. Yu. It became a matter for surgeons, pain clinicians and cancer doctors.
“Patients, or drug abusers, can get these kinds of drugs much more easily compared with 10 years ago,” Yu said. “That’s a problem.”
Yu read about what was happening in the U.S. and worried for China. “There is already a quite enormous group of drug users in this society,” he said.
Yu resisted the notion that opioid painkillers weren’t addictive and could be safely used, at any dose, for all kinds of pain. He checked the scientific references on clinical presentations and often found them unconvincing. He barred sales reps from his department.
Yu said he tried to persuade colleagues that some of the new notions about pain were silly, even risky. “I remember I argued with them, muscle pain or joint pain is not a good indication for opioid drugs,” he said. “But they said, it’s a human right. You have to relieve the pain.”

When Chen started work at Mundipharma, he was taught that OxyContin was a good drug, and widely used in America.
The company gave him hundreds of pages of documents to study. Chen read that the risk of getting addicted to opioid painkillers was virtually non-existent and that OxyContin’s slow-release formulation made it even safer. He didn’t bother to check the references Mundipharma cited as proof. Neither did most doctors at China’s notoriously overburdened hospitals. And the legal sanctions Purdue faced in the U.S. didn’t apply in China, where some people had never heard of the company or its troubles.
“I considered this a problem in terms of humanistic care for patients,” Chen said. “This is a really good product.”
In the 2007 lawsuit filed by U.S. prosecutors, Purdue conceded that some of its employees had falsely claimed that long-acting opioids are less addictive because they have fewer “peak and trough” effects and cause less euphoria. Purdue entered into a legally binding agreement with the U.S. government to ensure that their staff never made such claims again.
“Purdue accepted responsibility for the misconduct in 2007 and has since then strived never to repeat it,” the company said again in a legal filing in September.
Yet, three current and former employees of Purdue’s international affiliate in China made the same claim to AP that OxyContin reduces the risk of addiction because it is released slowly into the bloodstream, causing fewer “peaks and troughs” than immediate-release drugs. This argument has no scientific basis, according to a 2016 U.S. Centers for Disease Control report.
Sustained-release technology “further reduces the incidence of addiction,” reads a Mundipharma PowerPoint slide staff said was still in use last year. It referenced a study in the scientific journal Cancer from 1989 funded by Purdue and co-authored by a Purdue employee, and a brief 2004 Chinese study.
Neither paper actually examined addiction risk.
Some influential doctors in China also continue to make Mundipharma’s argument.
“The prolonged release formulation doesn’t easily give rise to drug dependence,” Dr. Fan Bifa, the director of the pain clinic at the China-Japan Friendship Hospital in Beijing, told the AP in May.
Dr. Fan has spoken at Mundipharma-funded conferences and appeared in a pain awareness video alongside Mundipharma China’s general manager, other prominent doctors and celebrities. The China-Japan Friendship Hospital was among the first to obtain certification under the Good Pain Management program in Beijing.
Fan told AP he has never taken money directly from Mundipharma.
When AP told Fan about Purdue’s 2007 guilty plea, he seemed shocked. He said he had never looked for scientific evidence to prove that sustained release opioids are less likely to cause addiction.
Other Mundipharma materials echoed a brief 1980 letter in the New England Journal of Medicine that has been repeatedly and incorrectly cited to suggest that opioids aren’t as addictive as everyone had long thought. Even after the journal “for reasons of public health” took the unusual step of publishing a cautionary editor’s note above the letter, it continued to be used in China.
“In the last 40 years, clinical studies at home and abroad have shown that the danger of opioid dependence occurring is less than 3/10,000,” proclaimed a Sept. 2017 press release for a Mundipharma-backed cancer pain awareness campaign.
Three current and former OxyContin sales reps repeated similar statistics to AP.
In a statement to AP, Mundipharma said that it “mandates warnings of addiction risk” in material used by sales representatives, but did not provide further detail. The package insert for OxyContin in China warns that it has the potential for abuse but also says “concerns about abuse, addiction, and diversion should not prevent proper use for pain treatment.”
The U.S. Centers for Disease Control says that as many as 1 in 4 people prescribed opioids for long-term use struggles with addiction.
The Mundipharma sales reps told AP they had a pitch for doctors worried about addiction: If used properly, the risks of addiction to opioid painkillers are virtually non-existent. Patients who seem addicted may just need more drugs to control pain, staff PowerPoints explained.
“Based on my experience, that’s like a joke,” Dr. Yu said.
He said patients could slip into addiction within a few days. “They came to you and started talking repeatedly about pain and asked you to prescribe medicine,” Yu said. “We call this drug-seeking behavior.’”
Mundipharma called it “pseudoaddiction.”
It is a notion first popularized by Dr. J. David Haddox, who coined the term “pseudoaddiction” in a 1989 paper. Haddox went on to spend nearly two decades as an executive at Purdue Pharma.
OxyContin’s FDA-approved label warns that even if taken as prescribed, OxyContin carries potentially lethal risks of addiction and abuse. Purdue now faces multiple U.S. lawsuits for spreading ideas about pseudoaddiction, as well as claiming the risk of opioid addiction is low and that doses can be increased without risk.
The idea that patients can safely take as much OxyContin as they want was great for Chen’s bottom line. Mundipharma sometimes offered special bonuses for selling 40 mg OxyContin, the largest, most expensive dose sold in China, internal documents and interviews show.
But Chen said cramming people full of pills “would lay heavy on my conscience.”
Chen flipped through a PowerPoint presentation on high-dose opioids he said he got from his boss at Mundipharma and pointed to an example of a patient taking 1500 mg twice a day.
“It’s terrifying,” he said.
A year after the CDC said that taking more than 33mg of OxyContin a day at least doubles the risk of overdose, Mundipharma came out with a marketing plan pushing its 40mg pill.
Mundipharma said its training covers “appropriate dosage levels for cancer patients” and provides information “in accordance with current best practice.”
As Chen looked back over his training documents, he found presentations touting opioid painkillers as a safe and effective treatment for chronic pain, citing outdated studies with authors linked to Mundipharma and other companies.
The co-author on a 2006 study of visceral pain went on to serve as a paid consultant for Mundipharma. One of the authors on another study, from 2003, cited as evidence that OxyContin is “ideal” for neuropathic pain, was a Mundipharma Canada employee. Mundipharma sourced OxyContin’s effectiveness for osteoarthritis pain to the American Academy of Pain Medicine, a professional society that attorneys general allege, in multiple lawsuits, is a paid front group for corporate interests.
In the U.S., Purdue also set out to change the culture of pain by first focusing on cancer. But from the beginning, Purdue was after the far larger non-cancer pain market, according to budget documents released by the Florida Attorney General’s office and published by Kaiser Health News.
The CDC says there are risks of “serious harms” from taking opioids long-term for chronic pain, but evidence for the potential benefits is lacking.
In a statement to AP, Mundipharma said that OxyContin “is used in practice only for the treatment of cancer pain in China.”
But under Chinese regulations, OxyContin can be used to treat moderate to severe pain, whether it’s caused by cancer or not. Government guidelines published in 2002 specify that strong opioids like OxyContin can be used after other methods have failed for non-cancer patients who are over 40 years of age and suffer from a handful of painful conditions.
But the guidelines are not rigorously followed. AP spoke with three doctors who said they prescribed OxyContin for a range of chronic pain conditions, though all said the numbers of non-cancer pain patients on OxyContin in China are small.
China’s National Health Commission, the National Medical Products Administration, the State Administration for Market Regulation and the National Development and Reform Commission all declined to comment on detailed questions from the AP.

If the U.S. has entered an endgame in its battle with prescription painkillers, China is somewhere near the beginning. While some people believe China’s painful history with opium and strict regulations will protect it against a U.S.-style outbreak, others fear for the future.
“Why am I afraid of a drug epidemic?” Dr. Yu said. “If our doctors can’t stand temptation and want to make tens or hundreds of thousands of yuan a month, it is easy to be manipulated by other people.”
Sitting in a large, Spartan office at Ruijin’s campus in suburban Shanghai, Yu had an air of resignation. His beliefs about how to shepherd people through suffering had fallen out of fashion in China. But Yu seemed at peace with his lost prestige.
In the end, he said, “it relies on the doctor’s conscience.”

Associated Press researcher Chen Si in Shanghai contributed to this report.
Follow Kinetz on Twitter at:
Online: A selection of Mundipharma China documents, U.S. court filings and regulatory guidelines

Help us tell more of the stories that matter from voices that too often remain unheard.

Source link

US News

Senate Approves Bills In Support Of Hong Kong Protesters

The Senate unanimously approved a pair of bills Tuesday meant to support the pro-democracy protests in Hong Kong that have caused mass demonstrations across the region for months.
Lawmakers passed the Hong Kong Human Rights and Democracy Act by unanimous consent, which would mandate that the State Department report annually on Hong Kong’s status as an autonomous territory of China. The legislation would also impose sanctions on any officials who commit human rights violations in Hong Kong.
“Today, the United States Senate sent a clear message to Hong Kongers fighting for their long-cherished freedoms: We hear you, we continue to stand with you, and we will not stand idly by as Beijing undermines your autonomy,” Sen. Marco Rubio (R-Fla.), a co-sponsor of the bill, said in a statement. “The passage of this bill is an important step in holding accountable those Chinese and Hong Kong government officials responsible for Hong Kong’s eroding autonomy and human rights violations.”
The legislation now goes to the House, where a similar version has already been approved. If passed, it will then be sent to President Donald Trump for consideration, although he has largely stayed quiet on the issue.
Millions have turned out en masse across the territory since June. The demonstrations initially opposed an extradition bill that would have allowed residents to be sent to mainland China for trial, a measure that was later withdrawn. But they have since grown to include calls for a broader change in government and resistance to encroachment from Beijing.

Keith Tsuji/SOPA Images/LightRocket via Getty Images

A Free HK sign during a Nov. 11 memorial rally at Tamar Park in Hong Kong to mourn the death of a 22-year-old university student, Alex Chow Tsz Lok, who died of a brain injury during a fall in a Nov. 4 skirmish with police.

The Chinese government has voiced strong opposition to the protests, and the country’s president, Xi Jinping, has supported Hong Kong’s leader, Carrie Lam. He has also called some of the protesters “violent criminals.”
“Halting the violence and restoring order remain the most important duty in Hong Kong at present,” Xi said earlier this month, according to China’s official news agency.
Though the demonstrations have largely been calm, some protests have grown violent in recent weeks, and dramatic images of people wielding Molotov cocktails and breaking windows have spread across social media. The police have responded with force, using tear gas and even opening fire at times with live rounds.
Many people have been injured, and a university student died after falling off a roof during a demonstration. The police have threatened to use more lethal force, prompting international condemnation.
“Today’s vote sends a clear message that the United States will continue to stand with the people of Hong Kong as they battle Beijing’s imperialism,” Sen. Josh Hawley (R-Mo.), who recently traveled to Hong Kong, said in a statement. “The Chinese Communist Party’s quest for power across the region is a direct threat to America’s security and prosperity.”
The Senate on Tuesday also unanimously passed legislation that would ban the export of certain crowd control munitions to the Hong Kong Police Force for a year, including tear gas, pepper spray and rubber bullets.
“Today, the U.S. Senate sent a strong and bipartisan message that the United States will not be complicit in the Chinese authorities’ crackdown on pro-democracy protesters,” Sen. Jeff Merkley (D-Ore.), a co-sponsor of the bill, said in a statement. “Day after day, we are seeing peaceful protesters being subjected to state-sponsored oppression, violence, and human rights abuses for demonstrating in support of a democratic future for Hong Kong. The U.S. should always stand with those seeking freedom and democracy, not with their oppressors.”

Help us tell more of the stories that matter from voices that too often remain unheard.

Source link

US News

Half The Men In The U.S. Are Uncomfortable With Female Political Leaders

Only 49% of American men say they would feel very comfortable with a woman as head of the government, according to a study released Tuesday morning of attitudes toward women and men in 11 countries. 
Women were a bit more likely to see their own leadership potential, but they’re still pretty sexist, too. Just 59% of American women surveyed said they’d be comfortable with a woman in charge, according to the Reykjavik Index, a survey of attitudes toward gender in the Group of Seven industrialized countries, as well as Brazil, China, India and Russia, conducted by consulting firm Kantar and Women Political Leaders, a nonprofit global coalition of female politicians based in Iceland. 
That only half of men are OK with a woman in charge is perhaps not surprising in the U.S., where a misogynist sits in the White House, a woman has never been president and there are still very few female governors. However, it is notable heading into an election where four women are vying for the Democratic nomination for president.
The results shouldn’t be interpreted to mean a woman doesn’t have a shot at the top spot, said Michelle Harrison, CEO of Kantar Public, a public policy consulting and research agency. A female politician’s road is just going to be a lot rougher.
That’s been clear already in the current nomination race, where the women running are facing an array of gendered critiques ― being called angry or elitist or schoolmarmish, for starters.
“Women in all walks of life have a harder job on the journey to leadership than men,” said Harrison, who worked on the study. “I don’t think it’s telling us anything specific about a particular woman. Leaders always break through.”
For the report, the researchers surveyed 22,000 adults ages 18 to 64 across the 11 countries ― including 2,000 Americans. The survey asked about women’s and men’s suitability for leadership roles across a number of areas, including government; business sectors like media, fashion, technology; and child care. 
The researchers found pervasive gender discrimination in every country surveyed. Nowhere were women and men viewed as equally suitable for leadership roles. Canada and the U.K. are the only countries in which a majority ― a slim one ― of men said they’d be very comfortable with a woman head of state. 

The researchers scored countries on an index, with 100 being perfect equality where women and men are viewed as equally capable. The lower the index score the more inequality there is.
Judged against other countries, the U.S. stands near the top, coming in third place with an index score of 75. Germany and France tied for first place, ranking at 77. The U.K.’s score dropped four points to 73 from 2018, knocking the country from first to fourth place.
Americans, men and women, were slightly more comfortable with a woman leader in the business sector. Sixty-one percent said they were comfortable with a female CEO.
There were some interesting differences across industries. Americans were more comfortable with female leaders in the media industry ― the index score there reached 82. Other industries scoring 82 (the highest ranking of all sectors) include the natural sciences and banking, which is somewhat surprising considering the prevalence of male CEOs in finance.
This is the second year Kantar and WPL have done this study, but the first time they’ve included countries outside the G-7, which includes the U.S., U.K., France, Germany, Italy, Japan and Canada.
The report finds discrimination against men, too. In every country, men were seen as less suitable leaders when it came to child care.
It is worth pausing to consider that people trust men to wage war and run the economy but not look after a toddler. 
“It’s laugh out loud,” said Harrison. “You can have your hand on the nuclear button, but we honestly don’t think you should be anywhere near the under-3s.”

Help us tell more of the stories that matter from voices that too often remain unheard.

Source link

US News

Hundreds Of Hong Kong Protesters Trapped Behind Barricades As Police Surround University

Hong Kong police have fired tear gas and rubber bullets to force back anti-government protesters trying to escape a university, in which hundreds of people are holed up with petrol bombs and homemade weapons amid fears of a bloody crackdown.
Dozens of people attempted to flee the Polytechnic University campus on Monday after a night of chaos in the Chinese territory, during which a police officer was shot with a bow and arrow, major routes were blocked and a bridge set on fire.
Protests have been raging in the former British colony for six months – at first in opposition to a highly controversial extradition bill, which could have seen Hong Kong residents detained in mainland China. 

Tyrone Siu / Reuters

Police detain protesters who attempt to leave the campus of Hong Kong Polytechnic University (PolyU) during clashes with police in Hong Kong on Nov.18, 2019. 

After the initial backlash, the bill was withdrawn, but protests have evolved into broader rebellions against both the police and what is perceived by some as the encroaching influence of Beijing.
Public broadcaster RTHK reported that “many” had been arrested near the campus, while in Nathan Road – the nearby commercial district – activists brought traffic to a halt and forced the closure of shopping centers.
“We’ve been trapped here for too long. We need all Hong Kongers to know we need help,” said Dan, a 19-year-old protester on the campus, as he burst into tears.
“I don’t know how much longer we can go on like this. We may need international help.”
The Hong Kong government involved a colonial-era emergency law in October banning faced masks commonly used by protesters. The High Court ruled on Monday the ban was “incompatible with the Basic Law.”

Remember you have life in your hands. Why do you need to push us to death?

The Basic Law is the mini-constitution setting the terms under which the former colony returned to China.
Following a group who had attempted to make a run for it in the morning, protesters tried again to escape in the afternoon – but were pushed back with volleys of tear gas. 
Thirty-eight people were wounded over Sunday night, the city’s Hospital Authority said, with eyewitnesses from Reuters describing protesters suffering burns from the chemicals in police water cannons. 
“Remember you have life in your hands. Why do you need to push us to death?” one person shouted at police from a campus rooftop as protesters wearing gas masks and clutching umbrellas looked for ways to escape.
Police urged protesters to “drop their weapons” and leave.

Tyrone Siu / Reuters

A protester is detained by riot police while attempting to leave the campus of Hong Kong Polytechnic University (PolyU) during clashes with police in Hong Kong on Nov. 18, 2019. 

“Police appeal to everyone inside the Polytechnic University to drop their weapons and dangerous items, remove their gas masks and leave… in an orderly manner,” they said in a statement.
“They should follow police instructions and must not charge at police cordons.”
Live video footage from the scene showed protesters sitting cross-legged in the road with their hands tied behind their backs as riot police watched over them. 
Police said they fired three live rounds when “rioters” attacked two officers who were attempting to arrest a woman. No one was wounded and the woman escaped amid a dramatic escalation of the unrest that has plunged the Asian financial hub into chaos for almost six months.

Thomas Peter / Reuters

Protesters, some of whom stand behind the umbrellas which have become a symbol of the protest, attempt to escape the campus.

Demonstrators are furious at what they see as Chinese meddling in Hong Kong’s promised freedoms when it returned to Chinese rule in 1997, and claim they are responding to excessive use of force by police.
China says it is committed to the “one country, two systems” formula granting Hong Kong autonomy, with the city’s police denying accusations they use undue violence.
However, the U.S. has condemned the “unjustified use of force” in Hong Kong, and has called on Beijing to protect the territory’s freedoms, a senior official in Donald Trump’s administration said.
Chinese soldiers in a base close to the university were seen on Sunday monitoring developments at the university with binoculars, some dressed in riot gear.
Chinese troops in shorts and T-shirts, some carrying red plastic buckets or brooms, emerged from their barracks on Saturday in a rare public appearance to help clean up debris.

Thomas Peter / Reuters

Police storm the burning barricade at the Hong Kong Polytechnic University (PolyU).

Chinese forces have appeared on Hong Kong’s streets only once since 1997, to help clear up after a typhoon last year.
Asked about the clean-up operation, Chinese Defense Ministry spokesman Wu Qian said their efforts were welcomed by Hong Kong citizens.
The city’s Cross-Harbour Tunnel, next to the Polytechnic University, linking Hong Kong island to the Kowloon peninsula, remained closed after protesters torched a bridge above the toll booths on Sunday.
Some train services and many roads across the Kowloon peninsula were closed. All schools were shut.
As police approached the barricaded front gate of the university in the predawn hours, protesters retreated into the campus and started fires at the gate and a footbridge.

We need to fight until the end. If we don’t fight, Hong Kong will be over.
Ah Lung, 19

As some protesters discussed attempting to leave, others reinforced the barricades and distributed boxes of petrol bombs around the site. 
Thousands of residents and protesters flocked to districts around the university including Tsim Sha Tsui, Jordan and Yau Ma Tei, to try to penetrate the riot-police lines to rescue the trapped students.
“If we can only hold on until dawn, more might come,” said one young activist in the university.
University President Teng Jin-Guang said he had brokered a truce with police to allow protesters to leave the campus peacefully, however it was unclear whether a truce was taking effect.
Some of those trapped on the sprawling red-brick campus close to the city’s harbor said they would never surrender.
“We need to fight until the end. If we don’t fight, Hong Kong will be over,” said Ah Lung, 19.
The unrest in Hong Kong poses the gravest popular challenge to Chinese President Xi Jinping since he came to power in 2012. Xi has said he is confident Hong Kong’s government can resolve the crisis.
Beijing denies interfering in Hong Kong’s affairs and has blamed Western countries for stirring up unrest.

Help us tell more of the stories that matter from voices that too often remain unheard.

Source link

US News

Trump Hails New Farm Aid Billions As Report Reveals Money Helps Wealthy, Southerners

President Donald Trump on Sunday hailed the new round of billions of dollars in taxpayer subsidies to help struggling farmers survive his trade war with China. But his praise follows a troubling report that the trade aid — a total over two years of $28 billion — is being disproportionately doled out to farmers in Trump-supporting southern states, and being paid to the largest, wealthiest farms and foreign corporations.
The Department of Agriculture said Friday it will begin making the second round of this year’s $16 billion in trade aid payments to farmers this week. 
Our great Farmers will recieve another major round of “cash,” compliments of China Tariffs, prior to Thanksgiving. The smaller farms and farmers will be big beneficiaries. In the meantime, and as you may have noticed, China is starting to buy big again. Japan deal DONE. Enjoy!— Donald J. Trump (@realDonaldTrump) November 17, 2019

The aid is not being paid “compliments of China tariffs,” as Trump tweets, but by the Market Facilitation Program funded by U.S. taxpayers. Trump’s tariffs on Chinese goods are paid by American companies that import the products and typically pass on costs to U.S. consumers.
Nor has China started to “buy big again,” as Trump claims. Though China purchased 50 million bushels of soy from American farmers in October, the American Farm Bureau Federation said it was still 76% below purchase levels before Trump launched his trade war.
Per FGIS #China has now purchased nearly 50 million bushels of #soybeans the last two weeks, YTD at 90.5 mbu. For context, it’s still 76% below pre #TradeWar levels @FarmBureau— John Newton (@New10_AgEcon) November 4, 2019

Also, smaller farmers will unlikely be the “big beneficiaries” of the aid, as Trump tweeted because aid is flowing to the largest and most successful farmers rather than aiding struggling operations, according to a study in August by the Environmental Working Group. More than half of the farm bailouts from January 2018 to April 2019 went to just a tenth of the recipients in the program, according to the study. The top 1% of farmers were paid an average of $183,000, while the bottom 80% averaged less than $5,000.
Trump’s praise for the aid follows by just days another critical report by Democrats on the Senate Committee on Agriculture, Nutrition, and Forestry, saying the aid package “treats farmers unfairly.”
Figures show that 95% of top payment rates are going to farmers in the South, even though they have been less affected by the trade war with China, and that significant payments have been made to wealthy farmers and foreign corporations, the report notes. 
Five Southern states receive the highest payments per acre under the program — Georgia, Mississippi, Alabama, Tennessee, and Arkansas. All voted for Trump, all but Georgia voted overwhelmingly for him. The analysis determined that farmers in the Midwest and Northern Plains have been hurt the most by the trade war. 
The report accused the Agriculture Department of doing nothing to direct aid to struggling small and medium farms, and farmers just starting out. Instead, the agency doubled payment limits, directing even more money to large, wealthy farming partnerships. The report also lashed the aid program for making commodity purchases from foreign-owned agricultural conglomerates, including $90 million paid to a subsidiary of Brazilian-owned JBS SA.
Meanwhile, farm fortunes continue to stumble. The Farm Bureau reported last month that farm bankruptcies were up 24%, with more on the way. In other data released last week, farm income fell in the third quarter from a year ago in each of the seven rural heartland states covered by the Kansas City Fed.

Help us tell more of the stories that matter from voices that too often remain unheard.

Source link

US News

Hong Kong Campus Protesters, Police Clash As Anti-Government Unrest Spreads

HONG KONG (Reuters) – Hong Kong protesters shot arrows and hurled petrol bombs from a barricaded university on Sunday at police who fired tear gas and water cannon in some of the worst violence in the Chinese-ruled city since anti-government unrest erupted five months ago.
Several protesters took up positions on the rooftops of Hong Kong Polytechnic University, armed with bows and arrows, as unrest spread across the territory’s central Kowloon district.
Police said a media liaison officer was treated in hospital after being hit by an arrow in the leg and another officer’s visor was struck by a metal ball although he was not hurt.

Adnan Abidi / Reuters

Protesters clash with police outside Hong Kong Polytechnic University (PolyU) in Hong Kong, China on November 17, 2019. (REUTERS/Adnan Abidi)

Protesters, who were sprayed with the blue liquid from water cannon, stripped off and hosed each other down to wash it off.
Police fired tear gas to try to break up protests on Nathan Road, a major thoroughfare in Kowloon’s Mong Kok district, which was strewn with loose bricks, and in Yau Ma Tei district, where successive volleys of gas canisters temporarily cleared the streets. Clashes intensified during the night.
“Rioters continue to launch hard objects and petrol bombs with large catapults at police officers,” police said in a statement. “Police warn that the violent activities in the Hong Kong Polytechnic University have escalated to rioting.”

Athit Perawongmetha / Reuters

Anti-government protesters stand amid smoke during clashes with police, outside Hong Kong Polytechnic University (PolyU) in Hong Kong, China on November 17, 2019. (REUTERS/Athit Perawongmetha)

Chinese soldiers in a base close to the university were seen monitoring developments with binoculars, some dressed in riot gear with canisters on their chests, Reuters witnesses reported.
Chinese troops in shorts and T-shirts, some carrying red plastic buckets or brooms, had emerged from their barracks on Saturday in a rare public appearance to help clean up debris.
The presence of China’s People’s Liberation Army (PLA) soldiers on the streets, even to clean up, risks stoking controversy about Hong Kong’s status as an autonomous area.

Athit Perawongmetha / Reuters

Anti-government protesters prepare molotov cocktails during clashes with police, outside Hong Kong Polytechnic University (PolyU) in Hong Kong, China on November 17, 2019. (REUTERS/Athit Perawongmetha)

Protesters are angry at perceived Communist Party meddling in the territory, whose freedoms were guaranteed when it returned to Chinese rule in 1997. Beijing denies interfering and has blamed foreign influences for the unrest.
Huge fires had lit up the sky at the Hong Kong Polytechnic University on Saturday night and into Sunday morning after protesters threw petrol bombs. In the university courtyard, Joris, 23, said students fired arrows to protect themselves.
“The protesters have been reacting to the police. We haven’t fought back as much as we could. I would be prepared for jail. We are fighting for Hong Kong,” the civil engineer told Reuters.
The campus is the last of five universities to be occupied by activists, who have used the site as a base to block the Cross Harbour tunnel, which connects Kowloon to Hong Kong island.
A police truck, deployed to clear the bridge above the tunnel, retreated in reverse after being set ablaze.

Laurel Chor / Reuters

Protesters attend an anti-government march in the district of Central in Hong Kong, China on November 17, 2019. (REUTERS/Laurel Chor)

“We are not afraid,” said third-year student Ah Long, who did not give his full name. “If we don’t persist, we will fail.”
The violence has posed the gravest popular challenge to Chinese President Xi Jinping since he came to power in 2012. Xi has said he is confident Hong Kong’s government can resolve the crisis.
Chinese troops have appeared on Hong Kong’s streets only once since 1997, to help clear up after a typhoon last year.
(Additional reporting by James Pomfret, Jessie Pang, Joyce Zhou, Kate Lamb and Tom Lasseter; Writing by Greg Torode and Nick Macfie; Editing by Philippa Fletcher and Edmund Blair)

Help us tell more of the stories that matter from voices that too often remain unheard.

Source link

US News

Leaked Documents Reveal ‘No Mercy’ Shown In China’s Muslim Internment Program: Report

Hundreds of pages of internal communications between Chinese officials detail the ruthless machinations behind the detention of an estimated 1 million Muslims in internment camps in recent years, according to The New York Times, which obtained the documents.
Many of the pages discuss how to handle a wave of students returning home only to find their families had been hauled away.
Directives issued by China’s ruling Communist Party tell officials in the Xinjiang region, which is home to millions of Uighurs and other predominantly Muslim ethnic groups, to send plainclothes police officers to meet with all of the returning students. The officers were then told to show “humane concern” for the students’ plight as they “stress[ed] the rules.”
As the students would learn, a points system had been set up to gauge which detained Uighurs deserved release. They were told that their individual behavior could hurt their relatives’ odds, according to the documents.
If students pressed further, asking whether their relatives had committed any crimes, officials were told to acknowledge that they had not. Rather, they were suspected of thought crime ― in the form of sympathy to Islamic extremists ― even if the relatives were very old or very young.
“Freedom is only possible when this ‘virus’ in their thinking is eradicated and they are in good health,” the documents stated, according to the Times.
The students themselves had been chosen by the party from among the brightest in their region to attend universities across the country as part of efforts to encourage party loyalty. But they were viewed as having potential to disrupt the internment program by posting “incorrect opinions” on social media, which would then spread nationwide, according to the documents. Although the students could not go see their family members, they were permitted to arrange video calls.
China’s Uighur Muslim detention program made global headlines in August 2018, when a group of United Nations human rights experts went public with reports of the camps. Due to China’s strict security measures, however, details about the network of camps have trickled out slowly.
The Communist Party describes the camps as reeducation and job-training centers established as a way to combat Islamist extremism in the Xinjiang region, which boasts rich reserves of natural resources. According to the Times, Chinese President Xi Jinping believes stability in the region requires a sweeping surveillance program to root out dissidents, as such people threaten to undermine the Communist Party’s image of strength.
Deaths and suicide attempts in the camps have been reported.
While dissent in Xinjiang has been documented for decades, the documents obtained by the Times show how the party’s scrutiny of the region intensified in the wake of an early 2014 attack by Uighur militants, who stabbed around 150 people at a crowded train station. Of those, 31 died. Several weeks earlier, two Uighur militants had staged a suicide bomb attack that killed 80 people during a visit by Xi to the region. The past decade has seen other deadly attacks there, as well.
According to the Times, the Chinese president used an April 2014 speech ― made in private to other senior officials ― to call for a fight against “terrorism, infiltration and separatism” using the “organs of dictatorship.” He called officials’ anti-terrorism tactics “too primitive” and said the party “must be as harsh as them,” referring to the militants and their weapons, “and show absolutely no mercy.”
Xi told Xinjiang officials to encourage neighbors to report on neighbors, and to emulate aspects of Americans’ response to 9/11, which had been previously reported. 
Internment escalated rapidly with the August 2016 appointment of Chen Quanguo to handle security in the Xinjiang region, who repeatedly began telling officials to “round up everyone who should be rounded up.”
The materials leaked to the Times include 200 pages of internal speeches by top officials, 24 official documents and 160 pages of directives and reports on the surveillance effort in the region. The paper said a member of the Chinese political establishment was responsible for the materials’ release; the leaker reportedly wished to see Xi answer for his merciless policies.
Read the full documents at The New York Times.

Help us tell more of the stories that matter from voices that too often remain unheard.

Source link

US News

Ex-Ethics Chief Uses Donald Trump’s Own Words Against President’s Defenders

The former head of the U.S. Office of Government Ethics on Friday bashed people who continue to defend Donald Trump with a lengthy Twitter thread.Walter Shaub ― who last month said officials who defend Trump are waging a “war on democracy” ― tweeted segments of 25 controversial statements that Trump has previously made about immigration, women, authoritarian leaders, violence and more.“If you are defending the corrupt and dangerous person who said these things, then these are your words too,” wrote Shaub, who was appointed by former President Barack Obama and resigned six months into the Trump administration.“May you be remembered for them always,” he added. Check out the full thread below:Well, she’s going to go through some thingsI would like you to do us a favor thoughwhen I decided to just do it, I said to myself—I said, you know, this Russia thing with Trump and Russia is a made-up storyWhen you’re a star, they let you do itRussia, if you’re listening— Walter Shaub (@waltshaub) November 15, 2019

we fell in love…he wrote me beautiful lettersIt is big, grand, on hundreds of acres, next to Miami international airport, has tremendous ballrooms and meeting rooms, and each delegation would have…its own 50 to 70 unit buildingnobody has directly pointed a finger [at MBS]— Walter Shaub (@waltshaub) November 15, 2019

Don’t be a tough guy. Don’t be a fool! I will call you later.I will tell you that President Putin was extremely strong and powerful in his denial todayWhen Mexico sends its people . . .very fine people, on both sidestruly the enemy of the people— Walter Shaub (@waltshaub) November 15, 2019

by the way, likewise, China should start an investigation into the Bidenswho, by the way, are no angelsThe Baltimore house of Elijah Cummings was robbed. Too bad!You know what we used to do in the old days when we were smart? Right? With spies and treason, right?— Walter Shaub (@waltshaub) November 15, 2019

Trade wars are good and easy to winmost beautiful piece of chocolate cake that you’ve ever seen—and President Xi was enjoying it [as the missiles struck]The law’s totally on my side, the president can’t have a conflict of interest[NATO is] obsolete— Walter Shaub (@waltshaub) November 15, 2019

when you prosecute the parents for coming in illegally, which should happen, you have to take the children away.any guy that can do a body slam, he’s my kind of — he’s my guyyou can take the hand awayThere are a lot of killers. You think our country’s so innocent?— Walter Shaub (@waltshaub) November 15, 2019

(If you are defending the corrupt and dangerous person who said these things, then these are your words too. May you be remembered for them always.)— Walter Shaub (@waltshaub) November 15, 2019

Source link

US News

12 Amazing Photos You Missed This Week

With the never-stopping news cycle, it’s easy to miss great images that fly under the radar. We’ve got you covered.

We’re highlighting exceptional photos from around the world for the week of Nov. 9 to 15. Check them out below. 
ABOVE: Ice needles cover autumnally colored leaves still hanging on a branch on Nov. 11, 2019, in Marktoberdorf, southern Germany. (Credit: Karl-Josef Hildenbrand/Getty Images.)

NASA via Getty Images

The planet Mercury is seen in silhouette (low center) as it transits across the face of the sun on Nov. 11, 2019. Mercury’s last transit was in 2016; the next won’t occur until 2032.

Issei Kato / Reuters

Dancers from Tokyo wearing traditional costumes perform during a celebration event on Nov. 9, 2019, a day before Japan’s Emperor Naruhito and Empress Masako’s royal parade in front of the Imperial Palace in Tokyo.

Tom Brenner / Reuters

A taxi cab passenger looks out the driver’s side window while passing through Times Square, following the Veterans Day Parade in Manhattan on Nov. 11, 2019. 

ISAAC LAWRENCE via Getty Images

Protesters sleep on a barricaded street outside the Hong Kong Polytechnic University on Nov. 15, 2019.

Lintao Zhang via Getty Images

Workers maintain an animatronic dinosaur at the Gengu Dinosaurs Science and Technology company on Nov. 13, 2019, in Zigong, Sichuan Province, China. There are hundreds of simulated-dinosaur manufacturers in Zigong, accounting for 85% of the world’s production.

Dan Kitwood via Getty Images

Silke Lohmann poses beside a wooly rhinoceros skull during a press preview at Summers Place Auctions on Nov. 14, 2019, in Billingshurst, England. The piece makes up part of a collection, including taxidermy and dinosaur skeletons, that will go up for sale on Nov. 19.


A man crosses the flooded St. Mark’s Square in Venice on Nov. 13, 2019, after an exceptional overnight “alta acqua” high tide water level.

Sergio Moraes / Reuters

A supporter of Venezuela’s President Nicolás Maduro fights with a supporter of opposition leader Juan Guaidó outside the Venezuelan Embassy in Brasilia, Brazil, on Nov. 13, 2019.

Mario Tama via Getty Images

A father hugs his daughter after being reunited at a park near Saugus High School, where a shooter killed two students and wounded three more on Nov. 14, 2019, in Santa Clarita, California. 

ANDREAS SOLARO via Getty Images

People take photos of Pope Francis with their smartphones as he arrives for an audience at the Vatican with students and teachers of Rome’s LUMSA Catholic university on Nov. 14, 2019.

PETER STEFFEN via Getty Images

A man walks a dog as the sun rises in Hanover, northern Germany, on Nov. 14, 2019. 

Help us tell more of the stories that matter from voices that too often remain unheard.

Source link